KALAMAZOO — Two deals that closed in recent weeks typify medical device firm Stryker Corp.’s acquisition strategy.

Published in Health Care

The $8 million that Innovative Cardiovascular Solutions LLC wants to raise in a new capital round would support completion of a clinical trial in Europe and pay for an upcoming U.S. trial.

Published in Health Care